4//SEC Filing
LEBEL FRANCOIS 4
Accession 0001209191-21-013884
CIK 0000831547other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:08 PM ET
Size
10.4 KB
Accession
0001209191-21-013884
Insider Transaction Report
Form 4
LEBEL FRANCOIS
Chief Medical Officer
Transactions
- Award
Common Stock, $0.001 par value
2021-02-18+110,309→ 418,526 total - Award
Stock Option (Right to Buy)
2021-02-18+133,708→ 133,708 totalExercise: $3.56Exp: 2031-02-18→ Common Stock (133,708 underlying) - Award
Stock Appreciation Right
2021-02-18+314,213→ 314,213 totalExercise: $3.56Exp: 2031-02-18→ Common Stock (314,213 underlying)
Holdings
- 7,226(indirect: By 401(k))
Common Stock, $0.001 par value
Footnotes (3)
- [F1]One third of the aggregate amount of restricted shares shall vest on each of February 18, 2022, 2023 and 2024, respectively.
- [F2]One third of the aggregate amount of option shares shall vest on each of February 18, 2022, 2023 and 2024, respectively.
- [F3]One third of the aggregate amount of stock appreciation rights shall vest on each of February 18, 2022, 2023 and 2024, respectively.
Documents
Issuer
SPECTRUM PHARMACEUTICALS INC
CIK 0000831547
Entity typeother
Related Parties
1- filerCIK 0001038704
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 5:08 PM ET
- Size
- 10.4 KB